Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19
Clinical trial NCT04498377 · TERMINATED
Trial details
- NCT number
- NCT04498377
- Sponsor
- EVIVE Biotechnology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2021-03-24
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.